KN
Kane Biotech Inc.
KNBIF · OTC
$0.02 +0.00% (+$0.00)
1M +17.30%
Market Cap $6.23M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 161.80x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 45.69%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 505.99%
Net margin 7,022.61%
Op. margin 8,162.01%
Quality
0 /100
Poor ROIC 312.41%
ROA 121.24%
Asset turnover 0.02x
Debt
6 /100
High Current ratio 0.61x
Int. coverage -17.23x
Debt/Equity N/A
Stability
32 /100
Unstable Beta 0.31x
Rev. volatility 798.91%
EPS volatility 22.98%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre KNBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Huizinga
Employees
20
Headquarters
Winnipeg
Evenimente viitoare
26 NOV.
Earnings
Upcoming earnings report